Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
150%(3 trials)
Terminated
2(40%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_3
1
20%
Ph phase_4
1
20%
Ph phase_2
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)

Detailed Status

Terminated2
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

not_yet_recruiting120%
terminated240%
completed240%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Acupuncture and Escitalopram for Treating Major Depression Clinical Study

NCT05901571
completedphase_4

Stress and Inflammation in Late-Life Depression

NCT02389465
terminatedphase_3

Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode

NCT02532660
terminatedphase_2

Adherence to Antidepressant Treatment in Subjects With Depression

NCT03388164
completedphase_2

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

NCT00807248

Clinical Trials (5)

Showing 5 of 5 trials
NCT05901571Not Applicable

Acupuncture and Escitalopram for Treating Major Depression Clinical Study

Not Yet Recruiting
NCT02389465Phase 4

Stress and Inflammation in Late-Life Depression

Completed
NCT02532660Phase 3

Study to Evaluate the Efficacy of LABCAT TCJUSS in Patients With Depressive Episode

Terminated
NCT03388164Phase 2

Adherence to Antidepressant Treatment in Subjects With Depression

Terminated
NCT00807248Phase 2

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

Completed

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5